北京时间5月29日收盘,ZNTL市盈率为-35.06,ZNTL市值为18亿美元

ZNTL简介

ZentalisPharmaceuticals,Inc.isaclinical-stagebiopharmaceuticalcompanyfocusedondiscoveringanddevelopingsmallmoleculetherapeuticstargetingfundamentalbiologicalpathwaysofcancers.Ituseitshighlyefficientdrugdiscoveryengine,whichitrefertoasitsIntegratedDiscoveryEngine,toidentifytargetsanddevelopsmallmoleculenewchemicalentities,orNCEs,withpropertiesthatitbelievecouldresultinpotentiallydifferentiatedproductprofiles.Itsdiscoveryenginecombinesitsextensiveexperienceandcapabilitiesacrosscancerbiologyandmedicinalchemistry.